See if you can get Medicaid
A 2021 study in published in NEJM of obese adults that used once-weekly injections found weight loss by 10% or more
December 10, 2025: People Who Lost Vision After Taking Ozempic May Be Able to Join Group Lawsuit Last week, the Judicial Panel on Multidistrict Litigation (JMPML) held a session to determine if a group lawsuit will be created for people who have GLP-1-related vision loss
Shaw RJ, Lamia KA, Vasquez D, Koo S-H, Bardeesy N, DePinho RA, et al
Organizations that cover GLP-1 drugs for weight loss typically do so through one of three ways: a prescription drug within a medical plan (85%), a dedicated weight management vendor point solution (12%) or a supplemental drug rider (4%)
A 52-week phase 2 trial on AMG133 in people with overweight and obesity is ongoing (NCT05669599)